Shilpa Bhatia

University of Washington — United States

Medicine · Health Sciences

25h-index2.2kcitations183works1.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(47), Axon Guidance and Neuronal Signaling(45), Pancreatic and Hepatic Oncology Research(35), Immune Cell Function and Interaction(27), Cancer Mechanisms and Therapy(26)

Publications182 total

Intramolecular Oxo Atom Migration to the <i>cis</i> Thiolate Sulfur of an Fe-Oxo Intermediate
Journal of the American Chemical Society·2025
Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC
Oncogene·2024· 4 citedOpen Access
The pro-tumoral and anti-tumoral roles of EphA4 on T regulatory cells and tumor associated macrophages during HNSCC tumor progression
2024· 1 citedOpen Access
Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC
2024Open Access
Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Nature Cancer·2024· 1 citedOpen Access
Figure S2 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Figure S2 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Figure S4 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Figure S6 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Supplementary Tables from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Figure S3 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Supplementary Legends from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Supplementary Methods from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Data from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Supplementary Methods from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Figure S5 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Figure S3 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Data from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Figure S4 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
Supplementary Legends from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Sana D. Karam(35), Ayman Oweida(22), Benjamin Van Court(17), Laurel B. Darragh(17), David Raben(15), Andy V. Phan(11), Eric T. Clambey(10), Michael W. Knitz(10), Jacob Gadwa(10), Thomas E. Bickett(10), Miles Piper(10), Shelby Lennon(8), Lynn E. Heasley(8), Diemmy Nguyen(8), Sanjana Bukkapatnam(7), Adam C. Mueller(7), Jaspreet Sharma(7), Antonio Jimeno(7), Paul B. Fisher(6), Dallin Milner(6)